Scientists have uncovered a potential approach to treat one of the commonest causes of dementia and stroke in older people.
Studies with rats found the treatment can reverse changes in blood vessels in the brain associated with the condition, called cerebral small vessel disease.
Treatment also prevents damage to brain cells caused by these blood vessel changes, raising hope that it could offer a therapy for dementia.
Small vessel disease, or SVD, is a major cause of dementia and can also worsen the symptoms of Alzheimer’s disease. It is responsible for almost half of all dementia cases in the UK and is a major cause of stroke, accounting for around one in five cases.
Patients with SVD are diagnosed from brain scans, which detect damage to white matter – a key component of the brain’s wiring.
Until now, it was not known how changes in small blood vessels in the brain associated with SVD can cause damage to brain cells.
A team led by the University of Edinburgh found that SVD occurs when cells that line the small blood vessels in the brain become dysfunctional. This causes them to secrete a molecule into the brain.
The molecule stops production of the protective layer that surrounds brain cells – called myelin – which leads to brain damage.
Treating rats with drugs that stop blood vessel cells from becoming dysfunctional reversed the symptoms of SVD and prevented brain damage, tests found.
Researchers say that further studies will need to test whether the treatment also works when the disease is firmly established. They will also need to check if the treatment can reverse the symptoms of dementia.
Dementia is one of the biggest problems facing society, as people live longer and the population ages. Estimates indicate there are almost 47 million people living with dementia worldwide and the numbers affected are expected to double every 20 years, rising to more than 115 million by 2050.
The research, published in Science Translational Medicine, was carried out at the Medical Research Council Centre for Regenerative Medicine and the UK Dementia Research Institute at the University of Edinburgh. It was funded by the MRC, Alzheimer’s Research UK and Fondation Leducq.
Professor Anna Williams, Group Leader at the University of Edinburgh’s MRC Centre for Regenerative Medicine, said: “This important research helps us understand why small vessel disease happens, providing a direct link between small blood vessels and changes in the brain that are linked to dementia. It also shows that these changes may be reversible, which paves the way for potential treatments.”
Dr Sara Imarisio, Head of Research at Alzheimer’s Research UK said: “Changes to the blood supply in the brain play an important role in Alzheimer’s disease as well as being a direct cause of vascular dementia. This pioneering research highlights a molecular link between changes to small blood vessels in the brain and damage to the insulating ‘white matter’ that helps nerve cells to send signals around the brain.
“The findings highlight a promising direction for research into treatments that could limit the damaging effects of blood vessel changes and help keep nerve cells functioning for longer. There are currently no drugs that slow down or stop Alzheimer’s disease and no treatments to help people living with vascular dementia. Alzheimer’s Research UK is very pleased to have helped fund this innovative research, which is only possible thanks to the work of our dedicated supporters.”
Learn more: Brain study paves way for therapy for common cause of dementia
The Latest on: Small vessel disease
[google_news title=”” keyword=”small vessel disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Small vessel disease
- FDA approves Imdelltra for patients with extensive-stage small cell lung canceron May 17, 2024 at 10:18 am
The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer.
- Colchicine Misses in Secondary Stroke Prevention, but Door Not Closed Yeton May 15, 2024 at 5:00 pm
The rationale for studying it in secondary stroke prevention comes from prior research demonstrating that inflammation plays a role in the pathogenesis of both first and recurrent strokes caused by ...
- To detect risk of stroke, tiny probe acts ‘like a microscope’ inside brain’s blood vesselson May 15, 2024 at 10:59 am
A probe using an optical fiber about one human hair wide was snaked into the brain's tiny blood vessels and gave clear pictures of problems that could develop into life-threatening strokes.
- Could a blood test someday be used predict whether someone will have a stroke?on May 13, 2024 at 2:31 pm
Researchers at UCLA looked at whether or not a simple blood test could one day diagnose if someone would have a stroke.
- How Does Vasculitis Involve The Immune System? A Review By Doctorson May 13, 2024 at 2:28 pm
Expert opinion from Priya Darshini Dweepala MBBS, DNB Respiratory Medicine · 6 years of experience · India Vasculitis is defined as the presence of inflammatory leukocytes in the blood vessel walls, ...
- Could a simple blood test predict stroke risk, vascular issues in the brain?on May 13, 2024 at 4:30 am
Researchers are devising a blood test that could pick up on tell-tale signs of cerebral small vessel disease, a top risk factor for stroke and cognitive decline.
- Aging white matter in the brain may affect stroke recovery, study findson May 10, 2024 at 8:03 am
A new study examines how age-related brain changes could be linked to stroke recovery. Researchers suggest areas of age-related damage to parts of the brain containing white matter may influence ...
- Study finds network of inflammatory molecules may act as biomarker for risk of future cerebrovascular diseaseon April 30, 2024 at 5:00 pm
Past studies have linked individual molecules in the IL-18 network to cerebral small vessel disease and stroke risk. However, the concentration of these individual molecules can fluctuate in ...
- Predicting Alzheimer's dementia in oldest of the oldon December 22, 2023 at 1:25 pm
By contrast, the severity of baseline A-beta burden, along with other markers of brain damage defined by the presence of white matter lesions (a marker of small vessel disease) and decrease in ...
via Bing News